Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Katjana Daskalow"'
Autor:
Thorsten Cramer, Katharina Detjen, Bertram Wiedenmann, David Pfander, Katjana Daskalow, Martina Welzel, Nadine Rohwer
Supplementary Figure 3 from Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9767192177ca239285c7222a316205fb
https://doi.org/10.1158/0008-5472.22375715.v1
https://doi.org/10.1158/0008-5472.22375715.v1
Autor:
Thorsten Cramer, Katharina Detjen, Bertram Wiedenmann, David Pfander, Katjana Daskalow, Martina Welzel, Nadine Rohwer
Supplementary Figure 1 from Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54bdf5c585d2c0625465b4dc3138772c
https://doi.org/10.1158/0008-5472.22375721
https://doi.org/10.1158/0008-5472.22375721
Autor:
Thorsten Cramer, Katharina Detjen, Bertram Wiedenmann, David Pfander, Katjana Daskalow, Martina Welzel, Nadine Rohwer
Supplementary Figure 2 from Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1e62f0a6375d82d443192c17119694
https://doi.org/10.1158/0008-5472.22375718
https://doi.org/10.1158/0008-5472.22375718
Autor:
Anja A. Kühl, Esther Raskopf, Thorsten Cramer, Nadine Rohwer, Bertram Wiedenmann, Katjana Daskalow, Christoph Loddenkemper, Evelyne Dupuy, Volker Schmitz
Publikováno v:
Journal of Molecular Medicine. 88:817-827
Hepatocellular carcinoma (HCC) is a hypervascularized tumor entity with association of arterial vessel density with poor prognosis. The hypoxia-inducible transcription factor HIF-1alpha represents a pivotal regulator of angiogenesis and is thought to
Autor:
S Lobitz, Katjana Daskalow, Thorsten Cramer, Nadine Rohwer, Thomas Jöns, Wolfgang Kemmner, Peter M. Schlag, M Vieth, Bertram Wiedenmann, Michael Höcker
Publikováno v:
British Journal of Cancer
Gastric adenocarcinoma is characterised by rapid emergence of systemic metastases, resulting in poor prognosis due to vanished curative treatment options. Better understanding of the molecular basis of gastric cancer spread is needed to design innova
Autor:
Burkhard Jandrig, Rudolf Volkmer, Jörg A. Schenk, Burkhard Micheel, Katjana Daskalow, Prisca Boisguerin
Publikováno v:
Bioscience, Biotechnology, and Biochemistry. 72:346-351
Monoclonal antibodies against S-tagged fusion proteins expressed in pET vectors were generated and further characterized. Most pET vectors contain a 15-meric S-tag as a fusion tag for the detection of recombinant proteins. Two antibodies, G18BA3 and
Autor:
Cristina Domingo, Edinam Agbenu, Maurice Demanou, Sergio Yactayo, Katjana Daskalow, Matthias Niedrig, Axel R. Schulz
Yellow fever (YF) remains an important public health problem in regions where the disease is endemic, with a dramatic upsurge in the number of cases in recent years. So far, extensive YF epizooties occurred in South America in 2008, and during the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d201cf8d983ee2b1d42e9b12edd6e6
https://europepmc.org/articles/PMC3043487/
https://europepmc.org/articles/PMC3043487/
Autor:
Katjana Daskalow, Esther Raskopf, Tilman Sauerbruch, Volker Schmitz, M.A. Gonzalez-Carmona, Jens Standop, G Decker, Sarah Hirt, Annabelle Vogt, Thorsten Cramer
Publikováno v:
Current pharmaceutical biotechnology. 13(11)
Control of VEGF signaling is an intense objective of pre-clinical and clinical studies in HCC disease with steadily increasing clinical application. Despite its emerging role, several aspects of anti-VEGF based treatments are poorly investigated, lik
Autor:
Katjana, Daskalow, Prisca, Boisguerin, Burkhard, Jandrig, Frank K H, Van Landeghem, Rudolf, Volkmer, Burkhard, Micheel, Jörg A, Schenk
Publikováno v:
Anticancer research. 30(5)
A monoclonal antibody against the potential tumor suppressor kinase-enhanced protein phosphatase 1 (PP1) inhibitor KEPI (PPP1R14C) was generated and characterized. Human KEPI was expressed in Escherichia coli and used to immunize Balb/c mice. Using h
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
A monoclonal antibody against the potential tumor suppressor kinase-enhanced protein phosphatase 1 (PP1) inhibitor KEPI (PPP1R14C) was generated and characterized. Human KEPI was expressed in Escherichia coli and used to immunize Balb/c mice. Using h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::afba17a4d608c2a6773166de1156ce04
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/32120
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/32120